Cowen and Company advice for Vertex Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| January 27, 2020 | Cowen and Company | Vertex Pharma | Buy | 250.00 USD | 4.54 % |
Advice details
New York - Op 27 jan herhalen de analisten van Cowen and Company hun koopadvies voor Vertex Pharma (ISIN: US92532F1003 / Mnemo: VRTX). Het 12-maands koersdoel wordt opwaarts bijgesteld van 220.0 USD naar 250.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 